GSK Takes Back Control of Korean OTCs To Combine With Pfizer Megabrands
Executive Summary
GSK is set to regain the rights to a portfolio of OTC brands in South Korea which it will combine with Pfizer megabrands such as Advil and Centrum to create a sizable consumer health footprint in the country.
You may also be interested in...
GSK And Pfizer Assemble Consumer Healthcare Leadership Team As JV Closes
Under Brian McNamara’s leadership, GSK Consumer Healthcare has begun to assemble a management team that combines talent from both GSK and Pfizer.
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.